MIG Capital LLC Has $59.63 Million Stock Holdings in Sotera Health Company $SHC

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

MIG Capital LLC reduced its position in Sotera Health Company (NASDAQ:SHC - Free Report) by 13.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,113,951 shares of the company's stock after selling 804,626 shares during the quarter. Sotera Health makes up 7.4% of MIG Capital LLC's portfolio, making the stock its largest holding. MIG Capital LLC owned approximately 1.80% of Sotera Health worth $59,629,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of SHC. Principal Financial Group Inc. increased its stake in shares of Sotera Health by 0.3% in the first quarter. Principal Financial Group Inc. now owns 352,388 shares of the company's stock valued at $4,109,000 after buying an additional 1,037 shares in the last quarter. New York State Teachers Retirement System increased its position in Sotera Health by 1.9% in the first quarter. New York State Teachers Retirement System now owns 59,273 shares of the company's stock worth $691,000 after purchasing an additional 1,100 shares during the period. Tower Research Capital LLC TRC increased its position in Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock worth $82,000 after purchasing an additional 1,640 shares during the period. Bank of Montreal Can increased its position in Sotera Health by 10.6% in the fourth quarter. Bank of Montreal Can now owns 18,184 shares of the company's stock worth $249,000 after purchasing an additional 1,740 shares during the period. Finally, Quarry LP acquired a new stake in Sotera Health in the fourth quarter worth about $28,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts recently commented on SHC shares. Piper Sandler lowered their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research report on Wednesday, April 23rd. The Goldman Sachs Group upgraded Sotera Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $14.00 to $17.00 in a report on Monday, May 5th. Wall Street Zen upgraded Sotera Health from a "buy" rating to a "strong-buy" rating in a report on Saturday. Finally, Barclays restated an "overweight" rating on shares of Sotera Health in a report on Friday, August 8th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Sotera Health has an average rating of "Buy" and an average price target of $16.00.

Sotera Health Trading Up 0.4%

NASDAQ:SHC opened at $15.80 on Tuesday. The business's 50-day simple moving average is $12.00 and its 200-day simple moving average is $12.08. Sotera Health Company has a fifty-two week low of $9.53 and a fifty-two week high of $17.08. The stock has a market capitalization of $4.49 billion, a PE ratio of 197.52 and a beta of 1.81. The company has a debt-to-equity ratio of 4.49, a current ratio of 2.47 and a quick ratio of 2.23.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its earnings results on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%. The business had revenue of $294.34 million for the quarter, compared to analyst estimates of $275.81 million. During the same quarter last year, the firm earned $0.19 EPS. Sotera Health's revenue for the quarter was up 6.4% compared to the same quarter last year. Sell-side analysts expect that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.